Kidney Disease Educational Benefits Act of 2009
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
55pct
6d open
vs 6,490 other HR bills in the 111th — cohort avg 44d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2010 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
Client expense: $370,000 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
2010 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
Client expense: $400,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2010 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
Client expense: $570,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2010 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2010 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
Client expense: $390,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2009 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 306, Kidney Disease Education Benefits Act of 2009
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 306, Kidney Disease Education Benefits Act of 2009
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 306, Kidney Disease Education Benefits Act of 2009
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 306, Kidney Disease Education Benefits Act of 2009
Client expense: $520,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE